Literature DB >> 15033129

Restless legs syndrome in blood donors.

Jan Ulfberg1, Birgitta Nyström.   

Abstract

BACKGROUND AND
PURPOSE: Restless legs syndrome (RLS) may be a cause of significant sleep disturbance. In a Swedish survey, the prevalence of RLS has been estimated to be 5.8% among men and 11.4% among women. Blood donation may result in iron deficiency, which is hypothesized to be one substantial cause of RLS. PATIENTS AND METHODS: Nine hundred and forty-six (618 men, 328 women) consecutive blood donors aged 18-64 years, who attended a blood donation unit in mid-Sweden, answered a questionnaire that included questions about sleep habits. Frequency of blood donation was recorded and intake of iron tablets was assessed. Red blood cell distribution width (RDW) was also recorded. The value of RDW increases in relation to iron deficiency.
RESULTS: RLS affected 14.7% of male and 24.7% of female blood donors. The mean intake of iron among the blood donors after each blood donation was only 781 mg, although the recommended intake is 2000 mg. Among the women, 7.4% presented an RDW of >14.5%, which strongly indicates iron deficiency. In this group of women, 37.5% were affected by RLS. The female RLS-sufferers were more affected than the female non-RLS subjects by problems initiating sleep (P=0.006 maintaining sleep (P<0.0001) and were also less refreshed upon awakening (P<0.001).
RESULTS: This study showed that RLS was common among female blood donors. Women with RLS were more iron-deficient than those without and were affected by impaired sleep.

Entities:  

Mesh:

Year:  2004        PMID: 15033129     DOI: 10.1016/j.sleep.2003.09.010

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  8 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors.

Authors:  Joseph E Kiss; Whitney R Steele; David J Wright; Alan E Mast; Patricia M Carey; Edward L Murphy; Jerry L Gottschall; Toby L Simon; Ritchard G Cable
Journal:  Transfusion       Date:  2013-04-26       Impact factor: 3.157

3.  Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome.

Authors:  Barbara J Bryant; Yu Ying Yau; Sarah M Arceo; Julie A Hopkins; Susan F Leitman
Journal:  Transfusion       Date:  2013-01-10       Impact factor: 3.157

Review 4.  Iron in Restless Legs Syndrome.

Authors:  Eva C Schulte; Maria Kaffe; Barbara Schormair; Juliane Winkelmann
Journal:  Mov Disord Clin Pract       Date:  2014-06-12

5.  High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.

Authors:  Susanne Macher; Camilla Drexler; Ines Lindenau; Nazanin Sareban; Peter Schlenke; Karin Amrein
Journal:  Trials       Date:  2016-10-28       Impact factor: 2.279

6.  Individuals with Restless Legs Syndrome Tend to have Severe Depressive Symptoms: Findings from a Community-Based Cohort Study.

Authors:  Chul-Hyun Cho; Leen Kim; Heon-Jeong Lee
Journal:  Psychiatry Investig       Date:  2017-11-07       Impact factor: 2.505

7.  The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.

Authors:  Susanne Macher; Cornelia Herster; Magdalena Holter; Martina Moritz; Eva Maria Matzhold; Tatjana Stojakovic; Thomas R Pieber; Peter Schlenke; Camilla Drexler; Karin Amrein
Journal:  Nutrients       Date:  2020-05-05       Impact factor: 5.717

8.  Ferritin Trajectories over Repeated Whole Blood Donations: Results from the FIND+ Study.

Authors:  Sara Moazzen; Maike G Sweegers; Mart Janssen; Boris M Hogema; Trynke Hoekstra; Katja Van den Hurk
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.